I expect stronger results in ph3 as the time vs body weight and dose rate are further understood. This was left largely open ended in ph2 and has exciting potential in my opinion. Hard to measure now though and I suspect potential partners may be exploiting this factor. Consequently I expect a smaller upfront but large backended deal.
NEU
Price at posting:
$3.05 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
